- $46.46m
- $28.33m
- $93.31m
Annual income statement for BGSF, fiscal year end - December 28th, USD millions except per share, conversion factor applied.
2021 December 26th | 2023 January 1st | R2023 December 31st | R2024 December 29th | 2025 December 28th | |
|---|---|---|---|---|---|
| Period Length: | 52 W | 53 W | 52 W | 52 W | 52 W |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 239 | 298 | 125 | 104 | 93.3 |
| Cost of Revenue | |||||
| Gross Profit | 80.9 | 104 | 49.8 | 38.4 | 33.3 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 224 | 282 | 122 | 110 | 102 |
| Operating Profit | 14.5 | 16.3 | 3.07 | -5.87 | -8.9 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 13.1 | 14.9 | -2.91 | -10.8 | -13.4 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 10.5 | 11.3 | -2.08 | -8.7 | -11.5 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 14.1 | 25.4 | -10.2 | -3.34 | -11.4 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 14.1 | 25.4 | -10.2 | -3.34 | -11.4 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.857 | 1.09 | -0.134 | -0.739 | -0.924 |
| Dividends per Share | |||||
| Special Dividends per Share |